PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
PEPG is expected to report earnings to fall 11.21% to -46 cents per share on March 19
Q4'25
Est.
$-0.46
Q3'25
Beat
by $0.04
Q2'25
Beat
by $0.11
Q1'25
Missed
by $0.20
Q4'24
Beat
by $0.13
The last earnings report on November 12 showed earnings per share of -51 cents, beating the estimate of -56 cents. With 203.52K shares outstanding, the current market capitalization sits at 352.62M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PEPG showed earnings on November 12, 2025. You can read more about the earnings report here.